Semafor reports FDA nominee Overton helped craft the case for cutting recommended childhood vaccines to 11
Heidi Overton, Trump's FDA nominee, helped craft the justification for cutting CDC-recommended childhood vaccines from 17 to 11, Semafor reported. The Senate health committee left without voting on her nomination, so confirmation falls to the lame-duck session.
Reality
- Evidence40
- Adoption
- Not scored
- Hype gap
- Not scored
- Incentives60
- Confidence45
Maka launches a $15-a-month kids' streaming app that does not maximize watch time
Maka launched a 25-show streaming app for children aged 0 to 6 at $15 a month, with no ads, autoplay or endless scrolling, Wired reported. With those levers gone, parents who keep paying are the clearest test of whether the design works.
Reality
- Evidence45
- Adoption
- Not scored
- Hype gap+20
- Incentives60
- Confidence55
Few young Medicaid patients with opioid use disorder stay on medication for six months
Scott Hadland's Medicaid study of nearly 230,000 youth with opioid use disorder found medication starts edged up while six-month retention may have fallen. Most patients are lost before that point, since five in six young people engaged in care receive no medication at all.
Reality
- Evidence55
- Adoption12
- Hype gap+10
- Incentives
- Not scored
- Confidence50
Severe cases account for 94% of GLP-1 prescriptions to obese children aged 8 to 11
GLP-1 prescriptions for obese children aged 8 to 11 have risen 310-fold since 2019, a transplant surgeon's study found. The surgeon wants severe cases treated early but concedes that long-term data on growth and puberty are still missing.
Reality
- Evidence45
- Adoption8
- Hype gap+15
- Incentives40
- Confidence40
US measles cases outpace the whole of 2025 by 52% with months left to count
US measles cases reached 3,471 by Sept. 17, about 52% more than in all of 2025, CDC figures show. New AAP guidance prepares clinicians for babies infected before birth, whose risk estimates rest on limited research.
Reality
- Evidence62
- Adoption
- Not scored
- Hype gap+15
- Incentives
- Not scored
- Confidence60
Off-label GLP-1 prescribing reaches one in eleven US children aged 8 to 11 with obesity
Prescribing has outrun the approval label for US children aged 8 to 11 with obesity. The trial behind the benefit claim followed them for 68 weeks. Those 68 weeks are the entire developmental record so far.
Reality
- Evidence50
- Adoption72
- Hype gap+14
- Incentives62
- Confidence55
A library dean would have readers classify an AI answer before trying to verify it
The University of Virginia's dean of libraries argues that accuracy is only one test of an AI answer, and sorts replies into four types that each permit a different kind of checking. The demonstration is two Google searches.
Reality
- Evidence42
- Adoption20
- Hype gap+15
- Incentives45
- Confidence55
An executive order splits MMR into three shots Merck stopped making in 2008
The Aug. 10 order also cuts the routine childhood list from 18 vaccines to 11 on the argument that the United States is out of step with Europe, and the pediatricians who have read it say no new safety or efficacy data came with it.
Reality
- Evidence66
- Adoption25
- Hype gap+45
- Incentives55
- Confidence58
People in 13 countries rank being listened to among the top five things that would move them
An Edelman Trust Institute and Yale poll found that people rank a doctor's listening and patience alongside the explaining of risks. It landed in the same week Robert F. Kennedy Jr. is due to keynote the group he chaired until December 2024.
Reality
- Evidence57
- Adoption30
- Hype gap+15
- Incentives62
- Confidence52
The Child Account tools in iOS 27, iPadOS 27 and macOS 27 put a parent's approval in front of new websites, contacts and downloads, and every device in a Family Sharing group has to be on the 27 releases first.
Reality
- Evidence60
- Adoption42
- Hype gap+18
- Incentives70
- Confidence66
Pediatricians are putting 8-year-olds on GLP-1s four years below the label age
Semaglutide's approval starts above age 12 and tirzepatide's obesity approval at 18, but a published study and one Dallas hospital's own count both show children under 12 already taking these drugs, mostly for obesity and type 2 diabetes.
Reality
- Evidence48
- Adoption52
- Hype gap+15
- Incentives62
- Confidence45
Massachusetts pediatricians who keep vaccine-hesitant families are testing dismissal's premise
Middleboro Pediatrics absorbs two or three newly dismissed families a week, which makes it one arm of a natural experiment whose other arm nobody is following and whose outcome measure nobody has defined.
Reality
- Evidence46
- Adoption34
- Hype gap+8
- Incentives44
- Confidence51